Key Takeaways from the RELATIVITY-047 Trial: Managing Advanced Melanoma
Source: Cancer Network , December 2024
Panelists discuss how the RELATIVITY-047 trial data highlights the efficacy of nivolumab plus relatlimab in managing advanced melanoma, offering improved progression-free survival with a favorable safety profile compared to with nivolumab alone.
